Bisphosphonates for men with prostate cancer: sifting through the rubble.
Kelly
William Kevin
WK
Steineck
Gunnar
G
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy; D010166:Palliative Care; D000077268:Pamidronate; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate